EORTC 18961: Post-operative adjuvant ganglioside GM2-KLH21 vaccination treatment vs observation in stage II (T3-T4N0M0) melanoma: 2nd interim analysis led to an early disclosure of the results / Eggermont, A.m., Suciu, S., Ruka, W., Marsden, J., Testori, A., Corrie, P., Aamdal, S., Ascierto, P., Patel, P., Spatz, A.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 26:15(2008).

EORTC 18961: Post-operative adjuvant ganglioside GM2-KLH21 vaccination treatment vs observation in stage II (T3-T4N0M0) melanoma: 2nd interim analysis led to an early disclosure of the results

Ascierto P;
2008

2008
EORTC 18961: Post-operative adjuvant ganglioside GM2-KLH21 vaccination treatment vs observation in stage II (T3-T4N0M0) melanoma: 2nd interim analysis led to an early disclosure of the results / Eggermont, A.m., Suciu, S., Ruka, W., Marsden, J., Testori, A., Corrie, P., Aamdal, S., Ascierto, P., Patel, P., Spatz, A.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - 26:15(2008).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014160
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 38
social impact